Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Alignment Healthcare (ALHC) Shares Outstanding (Diluted Average) (2022 - 2025)

Alignment Healthcare's Shares Outstanding (Diluted Average) history spans 4 years, with the latest figure at $198.0 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) rose 3.78% year-over-year to $198.0 million; the TTM value through Dec 2025 reached $198.0 million, up 3.78%, while the annual FY2025 figure was $198.0 million, 3.78% up from the prior year.
  • Shares Outstanding (Diluted Average) reached $198.0 million in Q4 2025 per ALHC's latest filing, down from $208.4 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $209.5 million in Q2 2025 to a low of $181.2 million in Q4 2022.
  • Average Shares Outstanding (Diluted Average) over 4 years is $191.7 million, with a median of $190.8 million recorded in 2024.
  • The largest YoY upside for Shares Outstanding (Diluted Average) was 9.76% in 2025 against a maximum downside of 2.43% in 2025.
  • A 4-year view of Shares Outstanding (Diluted Average) shows it stood at $181.2 million in 2022, then rose by 2.76% to $186.2 million in 2023, then increased by 2.46% to $190.8 million in 2024, then increased by 3.78% to $198.0 million in 2025.
  • Per Business Quant, the three most recent readings for ALHC's Shares Outstanding (Diluted Average) are $198.0 million (Q4 2025), $208.4 million (Q3 2025), and $209.5 million (Q2 2025).